What is the current policy for skin substitutes in Medicare?

Editorial team Published on

Medicare reimburses most skin substitutes (cellular and tissue-based products, or CTPs) at a flat national rate of roughly $127 per square centimeter, following a major payment overhaul that took effect January 1, 2026.

📊 Key 2026 Payment and Classification Changes

  • Reclassification: Non-BLA (Biologics License Application) skin substitutes are categorized as "incident-to" supplies rather than separate Part B biologicals.
  • Flat Rate: A standardized payment of ~$127/cm² applies uniformly across physician offices and hospital outpatient departments (HOPDs).
  • Wastage Rule: Medicare pays strictly for the portion of the product physically applied to the patient; discarded portions are non-billable and cannot use JW/JZ modifiers.
  • Biological Exception: Products licensed as biologicals under Section 351 of the PHS Act retain the traditional Average Sales Price (ASP) methodology.

✅ Coverage and Clinical Guidelines

  • Indications: Covered primarily for chronic, non-healing lower extremity wounds (diabetic foot ulcers, venous leg ulcers) that fail 4 weeks of standard conservative therapy.
  • Criteria: Wounds must measure ≥ 1.0 cm², be clean and granular, and show documented treatment response every 30 days.
  • Local Policies: While CMS withdrew sweeping uniform Local Coverage Determinations (LCDs) right before 2026, a regional patchwork of MAC (Medicare Administrative Contractor) rules and aggressive auditing for billing compliance remains active.

What are the CMS rules for skin substitutes in 2026?

Effective January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) overhauled Medicare Part B reimbursement for skin substitutes (cellular and acellular tissue products/CTPs), replacing old pricing models with a flat national rate of roughly $127.14 to $127.28 per square centimeter.

Key 2026 CMS Rules for Skin Substitutes

  • Flat National Payment Rate: Non-BLA (Biologics License Application) skin substitutes are paid a standardized rate of ~$127 per cm², ending the previous Average Sales Price (ASP) plus 6% pricing that allowed costs to exceed $2,000 per cm². Biologicals approved under Section 351 of the PHS Act still use the ASP methodology.
  • Reclassification as "Incident-to" Supplies: Non-BLA skin substitutes are categorized as incident-to supplies during a covered wound application procedure, meaning they are no longer billed as Part B drugs or biologicals.
  • Payment Tied to Applied Area Only: Medicare reimburses strictly for the portion of the product actually applied to the patient's wound. Discarded or unused portions are not paid or billable, and JW/JZ modifiers cannot be used.
  • Consistent Site-Neutral Policies: The rules apply uniformly across hospital outpatient departments (HOPDs), physician offices, and non-facility settings. Low-cost group HCPCS codes (C5271–C5278) in HOPDs were deleted, leaving high-cost application codes (15271–15278) for all applications.
  • Enforcement and Scrutiny: Driven by a surge in Medicare spending from $252 million in 2019 to over $10 billion in 2024, CMS and fraud operations have heightened audits focusing heavily on clinical documentation, medical necessity, and proper sizing measurements.

What are the 5 treatments that Medicare won't cover?

Original Medicare does not cover several major healthcare services, most notably routine dental care, hearing aids, routine vision care, long-term custodial care, and overseas medical care.

Major Uncovered Services

  • Routine Dental Care: Original Medicare does not pay for routine cleanings, fillings, tooth extractions, root canals, or dentures, except in rare surgical circumstances related to specific medical treatments.
  • Hearing Aids: Routine hearing tests, hearing aid fittings, and the devices themselves are completely excluded under traditional Medicare.
  • Routine Vision Care: Regular eye exams for prescription glasses, as well as contact lenses and eyeglasses, are not covered (aside from standard lenses after cataract surgery).
  • Long-Term Care: Ongoing custodial care—such as daily help with bathing, dressing, eating, or long-term nursing home stays—is not covered, as Medicare only pays for short-term skilled nursing rehabilitation.
  • Care Outside the United States: Medical treatments and services received while traveling internationally are generally not covered.

What is UHC's policy on skin substitutes?

UnitedHealthcare (UHC) considers EpiFix or Grafix medically necessary for treating diabetic foot ulcers only when specific clinical criteria are met, while designating over 150 other brand-name skin substitutes as unproven and not covered.

Covered Products and Indications

  • Approved Brands: EpiFix, Grafix (GrafixPL, GrafixPRIME, and GrafixPL PRIME [Non-injectable]).
  • Indication: Treatment of diabetic foot ulcers (all other uses are considered unproven).

Coverage Criteria for EpiFix / Grafix

To qualify for coverage, patients must meet key requirements including adequate circulation (ABI 0.7–1.2), an HbA1c level under 12%, at least 4 weeks of unsuccessful standard wound care, and no severe contraindications like active Charcot deformity or exposed bone/tendon.

How are skin substitutes billed?

Skin substitutes and cellular and tissue-based products (CTPs) are billed using a combination of application CPT codes and product-specific HCPCS codes tied to the actual surface area applied.

Under Medicare Part B rules, payment is split into two parts: the surgical application service and the product itself.

Core Billing Structure

  • Application Codes: Report application using CPT codes 15271–15278 (based on the anatomical site and total surface area in square centimeters). The application code and product code must be submitted on the same claim and date of service.
  • Product Pricing: For non-BLA (Biologics License Application) skin substitutes, CMS uses a flat national rate of $127.14 per square centimeter, classifying them as "incident-to" supplies rather than separately priced biologicals. Biological products licensed under Section 351 continue to use the Average Sales Price (ASP) methodology.
  • Wastage: Reimbursement is strictly tied to the surface area actually applied to the patient; unused or discarded product from single-use vials is generally not separately reimbursed under the updated flat-rate rules.

You can review specific operational guidelines and updates through the CMS Medicare Coverage Database.

"2026 Medicare Skin Substitute Rules CHANGED — Are You Billing Correctly?"

9 related questions found

What skin substitutes are currently approved by Medicare?

Medicare does not maintain a single nationwide "approved list" of individual brand-name skin substitutes (cellular and tissue-based products, or CTPs), but instead covers products that meet medical necessity criteria through local and regional policies.

Coverage Policy Overview

  • Indications: Generally covered for chronic, non-healing lower extremity wounds like diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).
  • Prerequisites: Wounds must fail to show adequate improvement (typically less than 50% healing) after at least 4 weeks of standard conservative care.
  • Local Decisions: Coverage and specific grouped product tiers are managed via Medicare Coverage Database guidelines administered through local Medicare Administrative Contractors (MACs).
  • Examples of Common Products: Frequently billed products include bioengineered options and tissue matrices like Apligraf, Grafix, Kerecis, EpiFix, and Integra, though coverage status for each must be verified against your specific regional MAC policy list.

What are the big changes coming to Medicare in 2026?

Major updates to Medicare in 2026 include an increase in the Part D out-of-pocket drug cap to $2,100, the introduction of the first government-negotiated drug prices, and higher Part A and Part B costs. You can view the formal cost breakdown on the CMS 2026 Fact Sheet.

Cost and Premium Adjustments

  • Part A Deductible: Rises to $1,736 per benefit period (up from $1,676 in 2025).
  • Part B Standard Premium: Increases to $205.50 per month, reflecting a roughly 10% rise from the previous year.
  • Medicare Advantage Out-of-Pocket Limit: Decreases slightly to a maximum of $9,250 for in-network services.

Prescription Drug (Part D) Changes

  • Out-of-Pocket Cap: The hard cap on annual out-of-pocket prescription drug costs climbs from $2,000 to $2,100.
  • Negotiated Pricing: For the first time, lower government-negotiated prices take effect for ten high-cost medications.
  • Payment Plans: Enrollees can continue or automatically renew participation in spreading out-of-pocket pharmacy expenses into monthly installments.

New Pilots and Rules

  • Prior Authorization Pilot: A pilot program rolls out in six states (New Jersey, Ohio, Texas, Oklahoma, Arizona, and Washington) to test prior authorization requirements within Original Medicare for select services and equipment.
  • Marketing Rules: CMS modified agent and broker rules, such as reducing the sales call recording retention requirement from 10 years to 6 years and removing certain mandatory call disclaimers.

What is the big mistake people make with Medicare?

The single biggest and most costly mistake people make with Medicare is missing enrollment deadlines, leading to permanent late-enrollment penalties and gaps in coverage.

Missing Enrollment Deadlines

  • Initial Enrollment Period (IEP): This window lasts for seven months. It starts three months before the month you turn 65, includes your birthday month, and ends three months after.
  • Late Penalties: Failing to sign up for Part B or Part D on time can trigger permanent monthly or yearly financial penalties added to your premiums.
  • Delayed Enrollment Confusion: Many people wrongly assume they can delay Medicare past age 65 just because they have health coverage like COBRA, a marketplace plan, or small-employer insurance.

Other Costly Medicare Mistakes

  • Ignoring Annual Changes: Sticking with automatic renewal without reading the Annual Notice of Change (ANOC) can result in unexpected costs, as drug lists and doctor networks shift every year.
  • Choosing Solely by Low Premiums: Picking a plan based only on a low monthly cost while ignoring total out-of-pocket expenses like deductibles, copays, and coinsurance.
  • Missing the Medigap Window: Forgetting to apply for a Medigap (Medicare Supplement) policy during your open enrollment window. After this six-month period, insurers can use medical underwriting to charge more or deny coverage.
  • Skipping Financial Assistance: Overlooking programs like Medicare Savings Programs or Part D Extra Help that assist with out-of-pocket medical and prescription expenses.

Can I deduct Medicare premiums taken out of my social security check?

Yes, you can deduct Medicare premiums withheld from your Social Security check on your federal income taxes, provided you itemize your deductions and your total medical expenses exceed 7.5% of your adjusted gross income (AGI).

How the Deduction Works

  • Itemizing required: To claim the deduction, you must file Form 1040 and itemize your deductions on Schedule A.
  • The 7.5% threshold: You can only deduct the portion of your total qualified medical expenses (including Medicare Parts A, B, C, D, and Medigap premiums, plus out-of-pocket costs like copays and prescription drugs) that goes over 7.5% of your AGI.
  • Self-employed exception: If you are self-employed and show a net profit, you may qualify for an above-the-line deduction for health insurance premiums without needing to itemize.

Finding Your Total Premiums

  • Form SSA-1099: The Social Security Administration sends you an annual Form SSA-1099. This document lists the exact total of your Medicare premiums that were withheld from your checks over the prior year.

What treatments are not covered by Medicare in 2026?

Original Medicare (Parts A and B) does not cover routine dental, vision, hearing care, and long-term custodial nursing home care in 2026.

Common Excluded Treatments and Services

  • Routine Dental Care: Cleanings, fillings, tooth extractions, root canals, and dentures are generally not covered (with minor exceptions related to specific cancer treatments, organ transplants, or dialysis).
  • Routine Vision Care: Standard eye exams for prescription eyeglasses, contacts, and regular glasses are excluded, except for one pair following cataract surgery.
  • Hearing Aids: Routine hearing exams, hearing aid fittings, and the devices themselves are not covered by Original Medicare.
  • Long-Term Care: Custodial care (help with daily living activities like bathing, dressing, or eating in a nursing home or at home) is excluded, though up to 100 days of skilled nursing is covered under strict conditions.
  • Outpatient Prescription Drugs: Standard Parts A and B do not pay for most outpatient prescriptions; a separate Part D Plan or Medicare Advantage is required.
  • Routine Foot Care: Trimming toenails or removing corns and calluses is not covered unless medically necessary for conditions like diabetes.
  • Cosmetic Surgery: Elective procedures meant to change physical appearance without medical necessity are excluded.
  • Alternative Medicine: Acupuncture and chiropractic care are largely not covered, with narrow exceptions for chronic low-back pain or spinal subluxation.
  • Overseas Care: Medical treatment outside the United States is generally excluded outside of very rare, localized exceptions (like certain cruise ship locations near U.S. ports).

You can review specific items or check official rules directly on Medicare.gov.